Summary:Purpose: This study analyzed changes in the heart rates of children receiving vagus nerve stimulation (VNS) therapy for pharmacoresistant epilepsy.Methods: Changes in the heart rates of ten children receiving VNS therapy for pharmacoresistant epilepsy were evaluated with polysomnographic recordings, including electrocardiogram (ECG), EEG, thoraco-abdominal distension, nasal airflow, and VNS artifacts. Measurements during stimulation were compared with those at baseline for each patient.Result: While the VNS therapy pulse generator was delivering stimulation, the heart rates of four children increased significantly (p < 0.01), decreased for one child, and increased at the end of the stimulation for one child. The heart rates of four children did not change. Changes in heart rate varied during VNS, within stimulation cycles for individual children and from one child to another. Changes in heart rate differed between rapid eye movement (REM) and non-REM (NREM) sleep states. Respiratory changes (increases in frequency and decreases in amplitude) were concomitant with the changes in heart rate.Conclusion: In this case series of children with pharmacoresistant epilepsy, cardiorespiratory variations occurred while the VNS therapy pulse generator was delivering stimulation. Understanding these variations may allow further optimization of VNS parameters. Key Words: Epilepsy-Vagus nerve stimulationHeart rate-Respiration.Vagus nerve stimulation (VNS) therapy has been used for treating pharmacoresistant epilepsy in Europe since 1994. Several studies have described the efficacy of this treatment (Handforth et al., 1998;DeGiorgio et al., 2000;Boon et al., 2001). The vagus nerve comprises large myelinated A fibers, small myelinated B fibers, and unmyelinated C fibers that transmit VNS signals. In animals, a decreased heart rate is an index for C fiber stimulation (Woodbury and Woodbury, 1990;McLachlan, 1993). Although intraoperative bradycardia and asystole associated with vagal activation has been reported (Asconapé et al., 1999;Tatum et al., 1999), many studies have reported the safety of VNS Therapy (Ben Menachem, 2001). However, changes in heart rate variability during VNS Therapy have been reported (Kamath, 1992;Setty et al., 1998;Frei and Osorio, 2001;Galli et al., 2003). The effects of VNS on heart rate have been investigated in an awake state (Kamath et al., 1992;Banzett et al., 1999;Binks et al., 2001) and in a mixed awake and sleep state (Frei and Osorio, 2001). Only one of these studies reported a change in heart rate in adults (Frei and Osorio, 2001), showing that VNS can induce a reduction in heart rate and a biphasic response of a reduction followed by an increase in heart rate. The key role of the vagus nerve in heart rate regulation led us to investigate the effect of VNS on heart rate during sleep in children receiving VNS Therapy. A previous study in our laboratory showed that VNS Therapy during sleep-induced respiratory changes. The time course of those respiratory variations was divided into three ...